the persantine aspirin trial is a double-blind multi-centered cooperative study focusing primarily on the question of whether the administration of the combination of aspirin and dipyridamole ( persantine ) will result in a greater reduction of cerebral or retinal infarction or death than the administration of aspirin alone .
C0012582
dipyridamole
C0700020
persantine